Catalyst Pharmaceutical
CPRX
CPRX
135 hedge funds and large institutions have $222M invested in Catalyst Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 50 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
26% less call options, than puts
Call options by funds: $233K | Put options by funds: $313K
Holders
135
Holding in Top 10
–
Calls
$233K
Puts
$313K
Top Buyers
| 1 | +$2.75M | |
| 2 | +$2.31M | |
| 3 | +$2.07M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.78M |
| 5 |
Millennium Management
New York
|
+$1.36M |
Top Sellers
| 1 | -$9.01M | |
| 2 | -$8.73M | |
| 3 | -$5.07M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.41M |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$694K |